Advertisement
Sergio Ramos SIPA USA/PA Images
Dexamethasone

Real Madrid deny allegation that Ramos breached anti-doping regulations

The allegations relate to the 2017 Champions League final.

REAL MADRID DENIED on Friday allegations their captain Sergio Ramos breached anti-doping regulations on the night of the 2017 Champions League final.

According to the German magazine Der Spiegel, Ramos failed to declare he had taken dexamethasone ahead of the match at the Millennium Stadium in Cardiff, in which Real beat Juventus 4-1.

In a statement the European champions said that Ramos “has never breached the anti-doping control regulations” and that Uefa “closed the matter immediately”, following the “verification of experts from the World Anti-Doping Agency, AMA, and Uefa itself”.

The club continued: “Regarding the rest of the content from the aforementioned publication, the club will not pronounce on evidence that is so insubstantial.”

Dexamethasone is a glucocorticoid on the banned list of the World Anti-Doping Agency (WADA). The substance can have anti-inflammatory effects and increase concentration.

WADA does not prohibit players taking dexamethasone before games, as long as it is declared during a doping test. Der Spiegel claims Ramos and the Real Madrid team doctor instead registered betamethasone, another glucocorticoid on WADA´s banned list.

However the magazine also reports that Uefa were satisfied the mistake was an administrative error and took no disciplinary action.

© Agence France-Presse

Subscribe to our new podcast, Heineken Rugby Weekly on The42, here:

‘People say Roy is ‘Mr Angry’ but he’s honestly not like that all the time’ – Robinson

Your Voice
Readers Comments
15
This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
Leave a Comment
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.

    Leave a commentcancel